{"id":9140,"date":"2026-08-28T18:28:42","date_gmt":"2026-08-28T18:28:42","guid":{"rendered":"https:\/\/salago.design\/?p=9140"},"modified":"2026-08-29T11:52:20","modified_gmt":"2026-08-29T11:52:20","slug":"biotech-rebrand-cost","status":"publish","type":"post","link":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/","title":{"rendered":"How Much Does a Biotech Rebrand Cost \u2014 and When Is It Worth It?"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Quick answer<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A biotech rebrand costs <strong>\u20ac20,000 to \u20ac45,000<\/strong> in 2026 for repositioning plus a new identity system, and <strong>\u20ac50,000 to \u20ac150,000 and up<\/strong> once a new website and launch assets are included. Life sciences sits in the upper half of the general B2B range for four specific reasons: the strategist has to absorb the science, regulated claims add review rounds, the asset list includes congress and publication materials that generic benchmarks omit, and delivery is usually pinned to an external date. Behind those numbers, senior European studios bill <strong>\u20ac90\u2013\u20ac140 per hour<\/strong>, a full rebrand runs <strong>12 to 16 weeks<\/strong> (up to six months with sub-brands or several languages), and company renaming adds <strong>\u20ac6,000\u2013\u20ac25,000<\/strong> with trademark clearance priced per territory. <strong>It is worth doing when the science has changed and the brand now contradicts it<\/strong> \u2014 after a pivot, a spin-out, a restructuring, or the move from research to commercial. <strong>It is not worth doing as a substitute for data.<\/strong> If your next raise is the reason you are asking, read the last two sections first.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>The figures in this article are <strong>European market references for 2026<\/strong>, taken from published agency pricing guides and life-science budget benchmarks. They are market references, not Salago\u2019s rates.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What a biotech rebrand costs in 2026<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The word \u201crebrand\u201d hides four very different purchases, and almost every disagreement about price is really a disagreement about which one is on the table. The right-hand column is the question that makes two quotes comparable \u2014 ask it before you compare numbers, not after.<\/p>\n\n\n\n<figure class=\"wp-block-table\">\n<table>\n<thead><tr><th>Scope<\/th><th>Market range (2026)<\/th><th>Typical duration<\/th><th>The question to ask before signing<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Brand diagnosis only<\/td><td>\u20ac2,500\u2013\u20ac7,000<\/td><td>3\u20135 days<\/td><td>Does the fee get credited against the project if we go ahead?<\/td><\/tr>\n<tr><td>Repositioning and narrative (no design)<\/td><td>\u20ac8,000\u2013\u20ac30,000<\/td><td>2\u20134 weeks<\/td><td>What do we receive that a new hire could act on without you in the room?<\/td><\/tr>\n<tr><td>Identity system, existing positioning<\/td><td>\u20ac10,000\u2013\u20ac30,000<\/td><td>6\u20138 weeks<\/td><td>Which positioning are you designing against, and who signed it off?<\/td><\/tr>\n<tr><td><strong>Full rebrand: positioning + identity<\/strong><\/td><td><strong>\u20ac20,000\u2013\u20ac45,000<\/strong><\/td><td><strong>12\u201316 weeks<\/strong><\/td><td>How many hours of our scientific team\u2019s time does your process assume?<\/td><\/tr>\n<tr><td>Rebrand + website + launch assets<\/td><td>\u20ac50,000\u2013\u20ac150,000+<\/td><td>4\u20136 months<\/td><td>Can you split the brand fee and the web fee into two figures?<\/td><\/tr>\n<tr><td>Company renaming + trademark screening<\/td><td>+\u20ac6,000\u2013\u20ac25,000<\/td><td>3\u20136 weeks<\/td><td>Is legal clearance included, and for which territories?<\/td><\/tr>\n<tr><td>Brand architecture across a pipeline<\/td><td>+30\u2013100%<\/td><td>+4\u20138 weeks<\/td><td>Are you pricing one brand or a system of programme brands?<\/td><\/tr>\n<\/tbody>\n<\/table>\n<figcaption class=\"wp-element-caption\">European market ranges by scope for 2026, cross-checked against two independent agency pricing guides and a life-science budget benchmark. Market references, not Salago\u2019s rates.<\/figcaption>\n<\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Two figures give useful context. Across all sectors, the average branding engagement lands around <strong>\u20ac65,000 over roughly eight months<\/strong> \u2014 inflated by enterprise rollouts, but a fair marker for where a full system ends up. And the sensible planning assumption is a <strong>10\u201315% contingency<\/strong> on top of whatever you sign, because in life sciences the asset list always turns out longer than the kick-off deck said.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why life sciences costs more than the general market<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A biotech rebrand and a fintech rebrand with the same deliverable list are not the same project. Six things add cost, and all six are askable.<\/p>\n\n\n\n<figure class=\"wp-block-table\">\n<table>\n<thead><tr><th>What adds cost<\/th><th>Effect on the fee<\/th><th>Why it moves the price<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Absorbing the science<\/td><td>+15\u201330%<\/td><td>Before anything can be simplified it has to be understood. A mechanism of action, a platform thesis and a regulatory pathway are weeks of reading and interviews that a consumer project never budgets.<\/td><\/tr>\n<tr><td>Two audiences with opposite proof thresholds<\/td><td>+10\u201325%<\/td><td>The same story has to convince a non-technical investor and a technical buyer. That is two message systems and two proof sets, not one with a different cover.<\/td><\/tr>\n<tr><td>Regulated and evidence-bound claims<\/td><td>+10\u201320%<\/td><td>Anything that reads as a therapeutic or performance claim goes through medical, legal or regulatory review. Every review round is calendar time, and calendar time is fee.<\/td><\/tr>\n<tr><td>The asset list nobody benchmarks<\/td><td>+\u20ac3,000\u2013\u20ac15,000<\/td><td>Scientific posters, congress booths, figure and data-visualisation standards, publication templates, investor decks. Generic rebrand quotes assume a website and a stationery set.<\/td><\/tr>\n<tr><td>Delivery pinned to an external date<\/td><td>+15\u201330%<\/td><td>A congress, a readout, a closing. Anchoring to a fixed date means overlapping phases and doubling the team for the last stretch.<\/td><\/tr>\n<tr><td>Company renaming<\/td><td>+\u20ac6,000\u2013\u20ac25,000<\/td><td>Most candidate names fail legal screening. The cost sits in the ones you discard, not the one you keep \u2014 and each additional territory is another clearance.<\/td><\/tr>\n<\/tbody>\n<\/table>\n<figcaption class=\"wp-element-caption\">The six factors that separate a life-science rebrand from a general B2B one. Each is a question you can put to a studio before signing.<\/figcaption>\n<\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">The company rebrand is not the drug name<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This is the most expensive confusion in the category, and being precise about it changes who you should be hiring.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Renaming your company<\/strong> is a trademark exercise. You screen candidates, clear them in the territories where you operate, and register. A branding studio can run this, usually with a trademark attorney alongside.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Naming a medicinal product<\/strong> is a regulatory exercise. In Europe, invented names for products going through the centralised procedure are reviewed by the EMA against criteria designed to prevent confusion and misleading claims, using safety-driven similarity analysis rather than trademark logic. Programmes routinely generate hundreds of candidates before a handful survive to submission, and the two reviews \u2014 trademark and regulatory \u2014 are separate hurdles a name has to clear independently.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The practical consequence: <strong>if a studio quotes you a company rebrand and a product name as one line item, that quote is not comparable to anyone else\u2019s<\/strong>, and it may be pricing regulatory work it is not equipped to do. Keep them as two budgets, or at minimum two clearly separated figures. For the record, this is a boundary we hold ourselves: we do brand and company naming, we do not do regulatory name clearance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">When a biotech rebrand is worth it<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The test is not whether the brand looks dated. It is whether <strong>the brand now says something the company no longer is<\/strong>. Five triggers meet that bar, and all five have visible 2026 precedent.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>The science changed.<\/strong> A pivot, a discontinued platform, a therapeutic area you left behind. When Molecular Health separated from its diagnostics business and refocused on its clinical-molecular database, it became Lucera; its CEO described the result as clarity, focus and agility being \u201cso much easier now\u201d. The old name described a business the company had exited.<\/li>\n\n\n<li><strong>A spin-out or a separation.<\/strong> A new legal entity needs a name and a story that stand on their own, and it needs them before the first investor conversation, not after.<\/li>\n\n\n<li><strong>A restructuring that changes the thesis.<\/strong> Galapagos became Lakefront Biotherapeutics in 2026 after winding down its cell therapy operation and keeping three small-molecule assets. Twenty-seven years of brand equity described a pipeline that no longer existed.<\/li>\n\n\n<li><strong>Research to commercial.<\/strong> The move from \u201cwe are studying this\u201d to \u201cyou can buy this\u201d changes the buyer, the proof and the objection set. The most common trigger, and the least dramatic, which is why it gets postponed.<\/li>\n\n\n<li><strong>A name that blocks growth.<\/strong> Unpronounceable, already taken in your expansion territory, or so tied to one indication that the second one sounds like a distraction.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">A word of caution about the case everyone cites. Onco3R Therapeutics became Coultreon Biopharma and announced a $125 million Series A. It is a real 2026 example \u2014 but a rebrand and a raise landing in the same quarter is <strong>correlation, and the causation almost certainly runs the other way<\/strong>: companies rebrand when they have news worth renaming around. Treat any agency that shows you that chart as evidence of their case-study skills, not of their effect on your valuation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">When it is the wrong thing to buy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The honest version, and the reason this section exists: a rebrand is a multiplier on a story that is already true. It does not create the story.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Early-stage biotech funding tightened measurably going into 2026. In the first quarter, seed and Series A investment came to <strong>50 rounds worth $2.3 billion, against 60 rounds worth $3.7 billion in the same quarter of 2025<\/strong> \u2014 ten fewer deals and $1.4 billion less capital. J.P. Morgan analysts described investors as prioritising companies \u201cwith established data packages, de-risked development and nearer-term catalysts\u201d. None of those three is a branding deliverable.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">So do not buy a rebrand when the honest answer to \u201cwhat changed?\u201d is \u201cnothing yet\u201d. Specifically, hold off when \u2014<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>the platform thesis is still moving, and the category you would claim could change again within two quarters;<\/li>\n\n\n<li>there is nobody with the authority to decide what the company will and will not claim \u2014 a rebrand run by committee produces a compromise nobody defends;<\/li>\n\n\n<li>the round closes in under eight weeks, in which case a positioning sprint and a rebuilt deck will do more than a full identity you cannot finish in time;<\/li>\n\n\n<li>the real problem is that the data is thin, in which case the money belongs in the data.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">The number to decide with<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Comparing two proposals on the headline fee is the standard budgeting mistake, and in biotech it is worse than elsewhere, because the horizon is not a round number of years \u2014 it is pinned to a milestone. Use this instead.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Monthly carrying cost = (quoted fee + internal time cost) \u00f7 months until the next milestone that would change the story<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The <strong>internal time cost<\/strong> is the part no quote contains, and in life sciences it is larger than average, because the people who have to be in the room are the ones whose time is most expensive: the CSO, the CMO, the founder, the head of regulatory. Budget 60\u2013150 hours of that seniority across interviews, workshops, claim review and asset migration. At a loaded \u20ac90\u2013\u20ac150 per hour, that is \u20ac5,400 to \u20ac22,500 \u2014 a further 15\u201340% on top of the fee.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The <strong>milestone horizon<\/strong> is what makes this vertical different. Do not use \u201cthree to five years\u201d. Use the next event that would force you to retell the story: a readout, a filing, a first commercial launch, a raise, an exit. If that event is eighteen months out, you are buying eighteen months of brand, and the arithmetic should say so.<\/p>\n\n\n\n<figure class=\"wp-block-table\">\n<table>\n<thead><tr><th>Monthly carrying cost<\/th><th>Rebrand before a readout<\/th><th>Rebrand after a readout<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Quoted fee<\/td><td>\u20ac40,000<\/td><td>\u20ac40,000<\/td><\/tr>\n<tr><td>Your team\u2019s time (60\u2013150 senior hours)<\/td><td>\u20ac15,000<\/td><td>\u20ac15,000<\/td><\/tr>\n<tr><td>True cost<\/td><td>\u20ac55,000<\/td><td>\u20ac55,000<\/td><\/tr>\n<tr><td>Months until the story changes again<\/td><td>14<\/td><td>42<\/td><\/tr>\n<tr><td><strong>Cost per month<\/strong><\/td><td><strong>\u20ac3,929<\/strong><\/td><td><strong>\u20ac1,310<\/strong><\/td><\/tr>\n<\/tbody>\n<\/table>\n<figcaption class=\"wp-element-caption\">The same project, bought on either side of a milestone that changes the story. Waiting for the readout does not make the brand cheaper \u2014 it makes each month of it three times cheaper, because it lasts.<\/figcaption>\n<\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">That is the whole argument for timing in one table. It is also why a studio that asks \u201cwhat is your next milestone?\u201d in the first call is worth more than one that asks for your budget.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How we approach it at Salago<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">We do not publish a rate card, for the reason set out at the top: the same word covers four different purchases and a single number would mislead more people than it helped. What we publish is the shape of the decision.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We scope after a diagnosis, not before one. The <a href=\"https:\/\/salago.design\/brand-audit\/\">Brand Audit<\/a> takes three to five days and exists to establish what you actually need \u2014 which, more often than the industry admits, is less than you came in for. From there: <a href=\"https:\/\/salago.design\/clarity-strategy-design\/\">Clarity<\/a> for positioning and narrative, <a href=\"https:\/\/salago.design\/visual-identity\/\">Identity<\/a> for the full verbal and visual system, and <a href=\"https:\/\/salago.design\/system-brand-experience\/\">System<\/a> when the rebrand has to reach a website, a congress and a sales conversation in the same cycle.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The work we are known for is the translation problem: taking something genuinely hard to explain and making it land with a non-specialist without losing what makes it true. That is what we did with GUA in biotech, and it is the same job in agtech and in climate \u2014 the science changes, the translation problem does not. What does change is who reads the brand: in agtech that is <a href=\"https:\/\/salago.design\/blog\/agtech-branding\/\">an agronomist rather than an investor<\/a>, and it reorganises the whole project.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">And the uncomfortable part, said out loud: if your positioning is settled and what you need is execution capacity, a production studio will do it faster and cheaper than we will. A strategic partner is worth paying for when \u201cwhat do we say now\u201d and \u201cwhy us\u201d are the open questions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Frequently asked questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\">\n<div class=\"schema-faq-section\" id=\"faq-question-920010\"><strong class=\"schema-faq-question\">How much does a biotech rebrand cost?<\/strong> <p class=\"schema-faq-answer\">Between \u20ac20,000 and \u20ac45,000 in 2026 for repositioning plus a new identity system, and \u20ac50,000 to \u20ac150,000 and above once a website and launch assets are included. Life sciences sits in the upper half of the general B2B range because the strategist has to absorb the science, claims go through review, and the asset list includes congress and publication materials that generic benchmarks leave out.<\/p><\/div>\n<div class=\"schema-faq-section\" id=\"faq-question-920011\"><strong class=\"schema-faq-question\">How long does a biotech rebrand take?<\/strong> <p class=\"schema-faq-answer\">Twelve to sixteen weeks for positioning plus identity, and four to six months once a new website and launch assets are in scope. Sub-brands, several languages or a pipeline of programme brands push it to the upper end. The most common cause of delay is not the studio \u2014 it is the number of internal approvers and the number of claim review rounds.<\/p><\/div>\n<div class=\"schema-faq-section\" id=\"faq-question-920012\"><strong class=\"schema-faq-question\">Is a rebrand worth it before a funding round?<\/strong> <p class=\"schema-faq-answer\">It is worth it when the story has genuinely changed and the current brand contradicts it: after a pivot, a spin-out, a restructuring or the move from research to commercial. It is not worth it as a substitute for evidence. Early-stage biotech funding tightened in 2026 and investors are prioritising established data packages and nearer-term catalysts. If the round closes in under eight weeks, a positioning sprint and a rebuilt deck beat a full identity you cannot finish.<\/p><\/div>\n<div class=\"schema-faq-section\" id=\"faq-question-920013\"><strong class=\"schema-faq-question\">What is the difference between renaming the company and naming a drug?<\/strong> <p class=\"schema-faq-answer\">Renaming the company is a trademark exercise: screen, clear in your territories, register. Naming a medicinal product is a regulatory exercise \u2014 in Europe, invented names in the centralised procedure are reviewed by the EMA against safety-driven criteria, separately from trademark clearance. They are two budgets and usually two suppliers. A quote that merges them is not comparable to anyone else\u2019s.<\/p><\/div>\n<div class=\"schema-faq-section\" id=\"faq-question-920014\"><strong class=\"schema-faq-question\">How much of our own team\u2019s time will a rebrand consume?<\/strong> <p class=\"schema-faq-answer\">Budget 60 to 150 hours of senior internal time across interviews, workshops, claim review and asset migration \u2014 and in life sciences that time belongs to the most expensive people in the company. At a loaded \u20ac90\u2013\u20ac150 per hour it adds \u20ac5,400 to \u20ac22,500 of real cost, or 15\u201340% on top of the fee. Ask any prospective studio how many hours of your team its process assumes; one that has never counted is telling you something.<\/p><\/div>\n<div class=\"schema-faq-section\" id=\"faq-question-920015\"><strong class=\"schema-faq-question\">Can we phase a rebrand to spread the cost?<\/strong> <p class=\"schema-faq-answer\">Yes, and for most biotechs it is the better structure: diagnosis, then positioning, then identity, then rollout, with a decision point between each. Phasing costs 5\u201310% more in total because of re-onboarding between stages, and it removes the much larger risk of committing \u20ac50,000 to a direction nobody has validated. Insist that each phase ends with something usable on its own.<\/p><\/div>\n<div class=\"schema-faq-section\" id=\"faq-question-920016\"><strong class=\"schema-faq-question\">Does a rebrand increase our valuation?<\/strong> <p class=\"schema-faq-answer\">There is no honest evidence that it does on its own. Companies that rebrand and then raise well usually rebrand because they had news worth renaming around. What a rebrand can do is remove friction: fewer minutes spent explaining what you do, fewer investors who file you into the wrong category, a narrative your whole team tells the same way. Those are real, and they are not a valuation multiple.<\/p><\/div>\n<div class=\"schema-faq-section\" id=\"faq-question-920017\"><strong class=\"schema-faq-question\">What does a biotech rebrand include that a general B2B one does not?<\/strong> <p class=\"schema-faq-answer\">Scientific poster and congress templates, figure and data-visualisation standards, publication-ready assets, an investor narrative that survives a technical audience, and a claims framework that survives regulatory or legal review. If a quote mentions none of these, it has been priced as a general B2B project and the gap will reappear later as change requests.<\/p><\/div>\n<div class=\"schema-faq-section\" id=\"faq-question-920018\"><strong class=\"schema-faq-question\">When is a rebrand the wrong thing to buy?<\/strong> <p class=\"schema-faq-answer\">When the platform thesis is still moving and the category could change again within two quarters; when nobody has the authority to decide what the company will and will not claim; when the round closes in weeks; or when the real problem is thin data. In all four cases the money buys a more expensive version of an unresolved decision.<\/p><\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\">In short<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u20ac20,000 to \u20ac45,000 for positioning plus identity, \u20ac50,000 to \u20ac150,000 and up once the website is in. Life sciences sits in the upper half of the general market for reasons you can ask about, one by one. But the number that decides whether the money was well spent is not the fee \u2014 it is <strong>the fee plus your team\u2019s hours, divided by the months until the next milestone that would change the story<\/strong>. Bought on the wrong side of a readout, the same project costs three times as much per month.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If you want the honest version of whether a rebrand is what you need right now, that is what the <a href=\"https:\/\/salago.design\/brand-audit\/\">Brand Audit<\/a> is for, or you can <a href=\"https:\/\/salago.design\/contact\/\">tell us where your brand stands and what the next milestone is<\/a> and we will tell you what we would scope and why.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Related reading: <a href=\"https:\/\/salago.design\/blog\/b2b-branding-cost\/\">how much a B2B branding project costs<\/a> \u2014 the same arithmetic across all of B2B, with the full scope table. <a href=\"https:\/\/salago.design\/blog\/consulting-firm-vs-execution-studio-vs-strategic-design-partner-what-to-choose-and-why\/\">Consulting firm vs execution studio vs strategic design partner<\/a> \u2014 who to buy this from. <a href=\"https:\/\/salago.design\/blog\/brand-positioning-for-b2b-a-practical-framework-to-differentiate-yourself\/\">Brand positioning for B2B<\/a> \u2014 what you are actually buying when you buy strategy. And <a href=\"https:\/\/salago.design\/blog\/branding-mistakes-in-growing-startups-mvp-narrative-and-differentiation\/\">the seven branding mistakes growing startups make<\/a>.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Quick answer A biotech rebrand costs \u20ac20,000 to \u20ac45,000 in 2026 for repositioning plus a new identity system, and \u20ac50,000 [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":9141,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"page_builder":"","_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[11],"tags":[],"class_list":["post-9140","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-branding"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biotech Rebrand Cost 2026 \u2014 and When It\u2019s Worth It<\/title>\n<meta name=\"description\" content=\"A biotech rebrand costs \u20ac20,000\u2013\u20ac45,000 in 2026, more with a website. Market ranges, what makes life sciences cost more, and when a rebrand is the wrong buy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biotech Rebrand Cost 2026 \u2014 and When It\u2019s Worth It\" \/>\n<meta property=\"og:description\" content=\"A biotech rebrand costs \u20ac20,000\u2013\u20ac45,000 in 2026, more with a website. Market ranges, what makes life sciences cost more, and when a rebrand is the wrong buy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/\" \/>\n<meta property=\"og:site_name\" content=\"Salago\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T18:28:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-29T11:52:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/salago.design\/wp-content\/uploads\/2026\/08\/salago-biotech-rebrand-monthly-carrying-cost-2026.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Cristian Salazar\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Cristian Salazar\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/\"},\"author\":{\"name\":\"Cristian Salazar\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/#\\\/schema\\\/person\\\/1d178dde771050ceaa76f2d20554bafd\"},\"headline\":\"How Much Does a Biotech Rebrand Cost \u2014 and When Is It Worth It?\",\"datePublished\":\"2026-08-28T18:28:42+00:00\",\"dateModified\":\"2026-08-29T11:52:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/\"},\"wordCount\":2865,\"publisher\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/salago.design\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/salago-biotech-rebrand-monthly-carrying-cost-2026.webp\",\"articleSection\":[\"Branding\"],\"inLanguage\":\"en-US\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/\",\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/\",\"name\":\"Biotech Rebrand Cost 2026 \u2014 and When It\u2019s Worth It\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/salago.design\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/salago-biotech-rebrand-monthly-carrying-cost-2026.webp\",\"datePublished\":\"2026-08-28T18:28:42+00:00\",\"dateModified\":\"2026-08-29T11:52:20+00:00\",\"description\":\"A biotech rebrand costs \u20ac20,000\u2013\u20ac45,000 in 2026, more with a website. Market ranges, what makes life sciences cost more, and when a rebrand is the wrong buy.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#breadcrumb\"},\"mainEntity\":[{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920010\"},{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920011\"},{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920012\"},{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920013\"},{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920014\"},{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920015\"},{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920016\"},{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920017\"},{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920018\"}],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#primaryimage\",\"url\":\"https:\\\/\\\/salago.design\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/salago-biotech-rebrand-monthly-carrying-cost-2026.webp\",\"contentUrl\":\"https:\\\/\\\/salago.design\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/salago-biotech-rebrand-monthly-carrying-cost-2026.webp\",\"width\":1200,\"height\":630,\"caption\":\"Monthly carrying cost = (quoted fee + internal time cost) \u00f7 months until the next milestone that would change the story. Figures are the worked example in this article; ranges are European market references, not Salago\u2019s rates.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/salago.design\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How Much Does a Biotech Rebrand Cost \u2014 and When Is It Worth It?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/\",\"name\":\"Salago Creative\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/salago.design\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/#organization\",\"name\":\"Salago\",\"alternateName\":\"Salago Design\",\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/salago.design\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/salago.png\",\"contentUrl\":\"https:\\\/\\\/salago.design\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/salago.png\",\"width\":1164,\"height\":460,\"caption\":\"Salago\"},\"image\":{\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.instagram.com\\\/salago.design\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/salago-design\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/#\\\/schema\\\/person\\\/1d178dde771050ceaa76f2d20554bafd\",\"name\":\"Cristian Salazar\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e4aa95092c35970e611df14052a1f14eb48868bd14c5df2fcd6fba250faaa687?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e4aa95092c35970e611df14052a1f14eb48868bd14c5df2fcd6fba250faaa687?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e4aa95092c35970e611df14052a1f14eb48868bd14c5df2fcd6fba250faaa687?s=96&d=mm&r=g\",\"caption\":\"Cristian Salazar\"},\"description\":\"Brand design and strategy are key to competing in today's constantly evolving environment. I work with CEOs, founders, and CMOs to transform complexity into clarity and that clarity into real growth. For over 10 years, I've led Salago, a strategic design studio in Madrid, working on projects for startups, scaleups, and global institutions. My approach combines creative direction, branding, and strategic thinking to build brands that inspire trust, align teams, and generate impact.\",\"sameAs\":[\"https:\\\/\\\/www.instagram.com\\\/cris_salago\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/cristiansalazargomez\\\/\"],\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/author\\\/cristian-salazar\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920010\",\"position\":1,\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920010\",\"name\":\"How much does a biotech rebrand cost?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Between \u20ac20,000 and \u20ac45,000 in 2026 for repositioning plus a new identity system, and \u20ac50,000 to \u20ac150,000 and above once a website and launch assets are included. Life sciences sits in the upper half of the general B2B range because the strategist has to absorb the science, claims go through review, and the asset list includes congress and publication materials that generic benchmarks leave out.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920011\",\"position\":2,\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920011\",\"name\":\"How long does a biotech rebrand take?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Twelve to sixteen weeks for positioning plus identity, and four to six months once a new website and launch assets are in scope. Sub-brands, several languages or a pipeline of programme brands push it to the upper end. The most common cause of delay is not the studio \u2014 it is the number of internal approvers and the number of claim review rounds.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920012\",\"position\":3,\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920012\",\"name\":\"Is a rebrand worth it before a funding round?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It is worth it when the story has genuinely changed and the current brand contradicts it: after a pivot, a spin-out, a restructuring or the move from research to commercial. It is not worth it as a substitute for evidence. Early-stage biotech funding tightened in 2026 and investors are prioritising established data packages and nearer-term catalysts. If the round closes in under eight weeks, a positioning sprint and a rebuilt deck beat a full identity you cannot finish.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920013\",\"position\":4,\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920013\",\"name\":\"What is the difference between renaming the company and naming a drug?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Renaming the company is a trademark exercise: screen, clear in your territories, register. Naming a medicinal product is a regulatory exercise \u2014 in Europe, invented names in the centralised procedure are reviewed by the EMA against safety-driven criteria, separately from trademark clearance. They are two budgets and usually two suppliers. A quote that merges them is not comparable to anyone else\u2019s.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920014\",\"position\":5,\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920014\",\"name\":\"How much of our own team\u2019s time will a rebrand consume?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Budget 60 to 150 hours of senior internal time across interviews, workshops, claim review and asset migration \u2014 and in life sciences that time belongs to the most expensive people in the company. At a loaded \u20ac90\u2013\u20ac150 per hour it adds \u20ac5,400 to \u20ac22,500 of real cost, or 15\u201340% on top of the fee. Ask any prospective studio how many hours of your team its process assumes; one that has never counted is telling you something.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920015\",\"position\":6,\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920015\",\"name\":\"Can we phase a rebrand to spread the cost?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, and for most biotechs it is the better structure: diagnosis, then positioning, then identity, then rollout, with a decision point between each. Phasing costs 5\u201310% more in total because of re-onboarding between stages, and it removes the much larger risk of committing \u20ac50,000 to a direction nobody has validated. Insist that each phase ends with something usable on its own.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920016\",\"position\":7,\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920016\",\"name\":\"Does a rebrand increase our valuation?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"There is no honest evidence that it does on its own. Companies that rebrand and then raise well usually rebrand because they had news worth renaming around. What a rebrand can do is remove friction: fewer minutes spent explaining what you do, fewer investors who file you into the wrong category, a narrative your whole team tells the same way. Those are real, and they are not a valuation multiple.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920017\",\"position\":8,\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920017\",\"name\":\"What does a biotech rebrand include that a general B2B one does not?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Scientific poster and congress templates, figure and data-visualisation standards, publication-ready assets, an investor narrative that survives a technical audience, and a claims framework that survives regulatory or legal review. If a quote mentions none of these, it has been priced as a general B2B project and the gap will reappear later as change requests.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920018\",\"position\":9,\"url\":\"https:\\\/\\\/salago.design\\\/en\\\/blog\\\/biotech-rebrand-cost\\\/#faq-question-920018\",\"name\":\"When is a rebrand the wrong thing to buy?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"When the platform thesis is still moving and the category could change again within two quarters; when nobody has the authority to decide what the company will and will not claim; when the round closes in weeks; or when the real problem is thin data. In all four cases the money buys a more expensive version of an unresolved decision.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biotech Rebrand Cost 2026 \u2014 and When It\u2019s Worth It","description":"A biotech rebrand costs \u20ac20,000\u2013\u20ac45,000 in 2026, more with a website. Market ranges, what makes life sciences cost more, and when a rebrand is the wrong buy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/","og_locale":"en_US","og_type":"article","og_title":"Biotech Rebrand Cost 2026 \u2014 and When It\u2019s Worth It","og_description":"A biotech rebrand costs \u20ac20,000\u2013\u20ac45,000 in 2026, more with a website. Market ranges, what makes life sciences cost more, and when a rebrand is the wrong buy.","og_url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/","og_site_name":"Salago","article_published_time":"2026-08-28T18:28:42+00:00","article_modified_time":"2026-08-29T11:52:20+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/salago.design\/wp-content\/uploads\/2026\/08\/salago-biotech-rebrand-monthly-carrying-cost-2026.png","type":"image\/png"}],"author":"Cristian Salazar","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Cristian Salazar","Est. reading time":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#article","isPartOf":{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/"},"author":{"name":"Cristian Salazar","@id":"https:\/\/salago.design\/en\/#\/schema\/person\/1d178dde771050ceaa76f2d20554bafd"},"headline":"How Much Does a Biotech Rebrand Cost \u2014 and When Is It Worth It?","datePublished":"2026-08-28T18:28:42+00:00","dateModified":"2026-08-29T11:52:20+00:00","mainEntityOfPage":{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/"},"wordCount":2865,"publisher":{"@id":"https:\/\/salago.design\/en\/#organization"},"image":{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#primaryimage"},"thumbnailUrl":"https:\/\/salago.design\/wp-content\/uploads\/2026\/08\/salago-biotech-rebrand-monthly-carrying-cost-2026.webp","articleSection":["Branding"],"inLanguage":"en-US"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/","url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/","name":"Biotech Rebrand Cost 2026 \u2014 and When It\u2019s Worth It","isPartOf":{"@id":"https:\/\/salago.design\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#primaryimage"},"image":{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#primaryimage"},"thumbnailUrl":"https:\/\/salago.design\/wp-content\/uploads\/2026\/08\/salago-biotech-rebrand-monthly-carrying-cost-2026.webp","datePublished":"2026-08-28T18:28:42+00:00","dateModified":"2026-08-29T11:52:20+00:00","description":"A biotech rebrand costs \u20ac20,000\u2013\u20ac45,000 in 2026, more with a website. Market ranges, what makes life sciences cost more, and when a rebrand is the wrong buy.","breadcrumb":{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#breadcrumb"},"mainEntity":[{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920010"},{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920011"},{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920012"},{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920013"},{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920014"},{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920015"},{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920016"},{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920017"},{"@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920018"}],"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#primaryimage","url":"https:\/\/salago.design\/wp-content\/uploads\/2026\/08\/salago-biotech-rebrand-monthly-carrying-cost-2026.webp","contentUrl":"https:\/\/salago.design\/wp-content\/uploads\/2026\/08\/salago-biotech-rebrand-monthly-carrying-cost-2026.webp","width":1200,"height":630,"caption":"Monthly carrying cost = (quoted fee + internal time cost) \u00f7 months until the next milestone that would change the story. Figures are the worked example in this article; ranges are European market references, not Salago\u2019s rates."},{"@type":"BreadcrumbList","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/salago.design\/en\/"},{"@type":"ListItem","position":2,"name":"How Much Does a Biotech Rebrand Cost \u2014 and When Is It Worth It?"}]},{"@type":"WebSite","@id":"https:\/\/salago.design\/en\/#website","url":"https:\/\/salago.design\/en\/","name":"Salago Creative","description":"","publisher":{"@id":"https:\/\/salago.design\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/salago.design\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/salago.design\/en\/#organization","name":"Salago","alternateName":"Salago Design","url":"https:\/\/salago.design\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/salago.design\/en\/#\/schema\/logo\/image\/","url":"https:\/\/salago.design\/wp-content\/uploads\/2026\/03\/salago.png","contentUrl":"https:\/\/salago.design\/wp-content\/uploads\/2026\/03\/salago.png","width":1164,"height":460,"caption":"Salago"},"image":{"@id":"https:\/\/salago.design\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.instagram.com\/salago.design","https:\/\/www.linkedin.com\/company\/salago-design"]},{"@type":"Person","@id":"https:\/\/salago.design\/en\/#\/schema\/person\/1d178dde771050ceaa76f2d20554bafd","name":"Cristian Salazar","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e4aa95092c35970e611df14052a1f14eb48868bd14c5df2fcd6fba250faaa687?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e4aa95092c35970e611df14052a1f14eb48868bd14c5df2fcd6fba250faaa687?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e4aa95092c35970e611df14052a1f14eb48868bd14c5df2fcd6fba250faaa687?s=96&d=mm&r=g","caption":"Cristian Salazar"},"description":"Brand design and strategy are key to competing in today's constantly evolving environment. I work with CEOs, founders, and CMOs to transform complexity into clarity and that clarity into real growth. For over 10 years, I've led Salago, a strategic design studio in Madrid, working on projects for startups, scaleups, and global institutions. My approach combines creative direction, branding, and strategic thinking to build brands that inspire trust, align teams, and generate impact.","sameAs":["https:\/\/www.instagram.com\/cris_salago\/","https:\/\/www.linkedin.com\/in\/cristiansalazargomez\/"],"url":"https:\/\/salago.design\/en\/blog\/author\/cristian-salazar\/"},{"@type":"Question","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920010","position":1,"url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920010","name":"How much does a biotech rebrand cost?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Between \u20ac20,000 and \u20ac45,000 in 2026 for repositioning plus a new identity system, and \u20ac50,000 to \u20ac150,000 and above once a website and launch assets are included. Life sciences sits in the upper half of the general B2B range because the strategist has to absorb the science, claims go through review, and the asset list includes congress and publication materials that generic benchmarks leave out.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920011","position":2,"url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920011","name":"How long does a biotech rebrand take?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Twelve to sixteen weeks for positioning plus identity, and four to six months once a new website and launch assets are in scope. Sub-brands, several languages or a pipeline of programme brands push it to the upper end. The most common cause of delay is not the studio \u2014 it is the number of internal approvers and the number of claim review rounds.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920012","position":3,"url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920012","name":"Is a rebrand worth it before a funding round?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"It is worth it when the story has genuinely changed and the current brand contradicts it: after a pivot, a spin-out, a restructuring or the move from research to commercial. It is not worth it as a substitute for evidence. Early-stage biotech funding tightened in 2026 and investors are prioritising established data packages and nearer-term catalysts. If the round closes in under eight weeks, a positioning sprint and a rebuilt deck beat a full identity you cannot finish.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920013","position":4,"url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920013","name":"What is the difference between renaming the company and naming a drug?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Renaming the company is a trademark exercise: screen, clear in your territories, register. Naming a medicinal product is a regulatory exercise \u2014 in Europe, invented names in the centralised procedure are reviewed by the EMA against safety-driven criteria, separately from trademark clearance. They are two budgets and usually two suppliers. A quote that merges them is not comparable to anyone else\u2019s.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920014","position":5,"url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920014","name":"How much of our own team\u2019s time will a rebrand consume?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Budget 60 to 150 hours of senior internal time across interviews, workshops, claim review and asset migration \u2014 and in life sciences that time belongs to the most expensive people in the company. At a loaded \u20ac90\u2013\u20ac150 per hour it adds \u20ac5,400 to \u20ac22,500 of real cost, or 15\u201340% on top of the fee. Ask any prospective studio how many hours of your team its process assumes; one that has never counted is telling you something.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920015","position":6,"url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920015","name":"Can we phase a rebrand to spread the cost?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes, and for most biotechs it is the better structure: diagnosis, then positioning, then identity, then rollout, with a decision point between each. Phasing costs 5\u201310% more in total because of re-onboarding between stages, and it removes the much larger risk of committing \u20ac50,000 to a direction nobody has validated. Insist that each phase ends with something usable on its own.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920016","position":7,"url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920016","name":"Does a rebrand increase our valuation?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"There is no honest evidence that it does on its own. Companies that rebrand and then raise well usually rebrand because they had news worth renaming around. What a rebrand can do is remove friction: fewer minutes spent explaining what you do, fewer investors who file you into the wrong category, a narrative your whole team tells the same way. Those are real, and they are not a valuation multiple.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920017","position":8,"url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920017","name":"What does a biotech rebrand include that a general B2B one does not?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Scientific poster and congress templates, figure and data-visualisation standards, publication-ready assets, an investor narrative that survives a technical audience, and a claims framework that survives regulatory or legal review. If a quote mentions none of these, it has been priced as a general B2B project and the gap will reappear later as change requests.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920018","position":9,"url":"https:\/\/salago.design\/en\/blog\/biotech-rebrand-cost\/#faq-question-920018","name":"When is a rebrand the wrong thing to buy?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"When the platform thesis is still moving and the category could change again within two quarters; when nobody has the authority to decide what the company will and will not claim; when the round closes in weeks; or when the real problem is thin data. In all four cases the money buys a more expensive version of an unresolved decision.","inLanguage":"en-US"},"inLanguage":"en-US"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/salago.design\/wp-content\/uploads\/2026\/08\/salago-biotech-rebrand-monthly-carrying-cost-2026.webp","_links":{"self":[{"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/posts\/9140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/comments?post=9140"}],"version-history":[{"count":2,"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/posts\/9140\/revisions"}],"predecessor-version":[{"id":9155,"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/posts\/9140\/revisions\/9155"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/media\/9141"}],"wp:attachment":[{"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/media?parent=9140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/categories?post=9140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/salago.design\/en\/wp-json\/wp\/v2\/tags?post=9140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}